Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study
- PMID: 23090927
- PMCID: PMC3552525
- DOI: 10.1093/cid/cis908
Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study
Abstract
Background: The significance of hepatitis B core antibody (anti-HBc) without hepatitis B surface antigen (HBsAg) or hepatitis B surface antibody (anti-HBs) is unclear.
Methods: This cohort study included men enrolled in the Multicenter AIDS Cohort to determine clinical and laboratory predictors of isolated anti-HBc.
Results: A total of 2286 subjects (51% human immunodeficiency virus [HIV]-infected) were followed over 3.9 years. Overall, 16.9% (387) had at least 1 visit with isolated anti-HBc. The isolated anti-HBc pattern was stable 84% of the time, and transitioned to or from a pattern of past infection (anti-HBc and anti-HBs). Isolated anti-HBc was associated with HIV infection (odds ratio [OR], 2.19; 95% confidence interval [CI], 1.73-2.79) and hepatitis C virus (HCV; OR, 4.21; 95% CI; 2.99-5.91). The HCV association was stronger for chronic HCV infection (OR, 6.76; 95% CI, 5.08-8.99) than for cleared HCV (OR, 3.03; 95% CI, 1.83-5.03). HIV infection, chronic HCV, and cleared HCV infection all remained associated with isolated anti-HBc in multivariable models (OR, 1.74; 95% CI, 1.33-2.29; OR, 6.24; 95% CI, 4.62-8.42; and OR, 2.77; 95% CI, 1.65-4.66, respectively). Among HIV-infected subjects, highly active antiretroviral therapy was negatively associated (OR, 0.79; 95% CI, .66-.95) with isolated anti-HBc.
Conclusions: Isolated anti-HBc is associated with HIV and HCV coinfection, especially active HCV replication, and most commonly occurs as a transition to or from the pattern of natural immunity (anti-HBc and anti-HBs). The isolated anti-HBc pattern likely represents resolved HBV infection with low or undetected anti-HBs.
Figures
Similar articles
-
Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women.Clin Infect Dis. 2009 Jul 1;49(1):148-54. doi: 10.1086/599610. Clin Infect Dis. 2009. PMID: 19480573 Free PMC article.
-
Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.J Acquir Immune Defic Syndr. 2010 Jun;54(2):122-8. doi: 10.1097/QAI.0b013e3181daafd5. J Acquir Immune Defic Syndr. 2010. PMID: 20386111
-
Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.Int J STD AIDS. 2009 May;20(5):336-8. doi: 10.1258/ijsa.2008.008377. Int J STD AIDS. 2009. PMID: 19386971
-
Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.Curr HIV/AIDS Rep. 2018 Apr;15(2):172-181. doi: 10.1007/s11904-018-0379-y. Curr HIV/AIDS Rep. 2018. PMID: 29572624 Free PMC article. Review.
-
The underlying mechanisms for the 'anti-HBc alone' serological profile.Arch Virol. 2010 Feb;155(2):149-58. doi: 10.1007/s00705-009-0559-6. Epub 2009 Nov 29. Arch Virol. 2010. PMID: 20091193 Review.
Cited by
-
Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen.Diagnostics (Basel). 2024 Mar 29;14(7):728. doi: 10.3390/diagnostics14070728. Diagnostics (Basel). 2024. PMID: 38611641 Free PMC article. Review.
-
Living with HIV and Getting Vaccinated: A Narrative Review.Vaccines (Basel). 2023 Apr 25;11(5):896. doi: 10.3390/vaccines11050896. Vaccines (Basel). 2023. PMID: 37243000 Free PMC article. Review.
-
Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome.Front Cell Infect Microbiol. 2023 Apr 14;13:1143346. doi: 10.3389/fcimb.2023.1143346. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37124041 Free PMC article.
-
Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.PLoS One. 2020 Nov 19;15(11):e0242577. doi: 10.1371/journal.pone.0242577. eCollection 2020. PLoS One. 2020. PMID: 33211768 Free PMC article.
-
Isolated Anti-HBc: Significance and Management.J Clin Med. 2020 Jan 11;9(1):202. doi: 10.3390/jcm9010202. J Clin Med. 2020. PMID: 31940817 Free PMC article. Review.
References
-
- Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–39. - PubMed
-
- Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the national institutes of health, the HIV medicine association of the infectious diseases society of America, the pediatric infectious diseases society, and the American academy of pediatrics. MMWR Recomm Rep. 2009;58(RR-11):1–166. - PMC - PubMed
-
- Neau D, Winnock M, Galperine T, et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med. 2004;5:171–3. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
